Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Resiliency Training in Adolescents With NF1 and NF2; A Randomized Controlled Trial Via Secure Live Video Conferencing to Improve Emotional, Social and Physical Function

NCT03873610 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03873610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03873610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Resiliency Training in Adolescents With NF1 and NF2; A Randomized Controlled Trial Via Secure Live Video Conferencing to Improve Emotional, Social and Physical Function
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 15, 2019
Completion date
February 20, 2026
Enrollment
196 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurofibromatoses